Guthaus, E;Schmiedeberg, N;Bürgle, M;Magdolen, V;Kessler, H;Schmitt, M.The urokinase receptor (uPAR, CD87) as a target for tumor therapy: uPA-silica particles (SP-uPA) as a new tool for assessing synthetic peptides to interfere with uPA/uPA-receptor interaction..Recent Results Cancer Res.2003.162.3-14

Harbeck, N;Thomssen, C.[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast].Zentralbl Gynakol.2003.125.9.362-7

Harbeck, N.[Adjuvant chemotherapy in primary carcinoma of the breast].Zentralbl Gynakol.2003.125.9.322-6

Roggel, F;Hocke, S;Lindemann, K;Sinz, S;Welk, A;Bösl, M;Pabst, M;Nusser, N;Braun, S;Schmitt, M;Harbeck, N.Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance..Recent Results Cancer Res.2003.162.89-100

Schneeweiss, A;Thomssen, Ch;Harbeck, N;Bastert, G.[Prognostic factors in carcinoma of the breast. Thereupon depends success of the treatment].MMW Fortschr Med.2003.145.24.34-6, 38

Harbeck, N.[Interview with private lecturer Dr. med. Nadia Harbeck, Munich. Prognostic markers guide therapy (interview by Jochen Aumiller)].MMW Fortschr Med.2003.145.3-4.8, 10

Schmutzler, R;Schlegelberger, B;Meindl, A;Gerber, WD;Kiechle, M.[Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD].Zentralbl Gynakol.2003.125.12.494-506

Mettler, L;Audebert, A;Lehmann-Willenbrock, E;Jacobs, VR;Schive, K.New adhesion prevention concept in gynecological surgery..JSLS.2003.7.3.207-9

Paepke, S;V Minckwitz, G;Kaufmann, M;Schwarz-Boeger, U;Jacobs, VR;Aigner, M;Pfeifer, K;Ehmer, M;Hüttner, C;Blohmer, JU;Kiechle, M.[Chemoprevention of breast cancer: a literature review and report on the current status in Germany].Zentralbl Gynakol.2003.125.9.338-45

Morrison, JE;Jacobs, VR.Reduction or elimination of postoperative pain medication after mastectomy through use of a temporarily placed local anesthetic pump vs. control group..Zentralbl Gynakol.2003.125.1.17-22